Trinity, Florida Clinical Trials

A listing of Trinity, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 119 clinical trials
Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis

SPH3127-US-01 is a multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics, and preliminary efficacy of SPH3127 for the treatment of mild-to-moderate ulcerative colitis.

hematochezia
Clinical Research of West Florida
 (13.6 away) Contact site
  • 3 views
  • 20 Apr, 2022
  • +15 other locations
Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF na ve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

This is a randomized, double-blinded, placebo-controlled, Phase 3 study to evaluate the efficacy and safety of tildrakizumab compared to placebo in anti-TNF nave subjects with active PsA .

Sunpharma site no. 02
 (8.5 away) Contact site
  • 0 views
  • 11 Nov, 2021
  • +13 other locations
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of tildrakizumab in Subjects with Active Psoriatic Arthritis I (INSPIRE 1)

Sunpharma site no. 05
 (8.5 away) Contact site
  • 6 views
  • 14 Nov, 2021
  • +50 other locations
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will assess the safety and efficacy of the combination use of ubrogepant for the acute treatment of migraine headache in participants taking atogepant once daily for preventive …

Suncoast Clinical Research /ID# 242463
 (5.4 away) Contact site
  • 0 views
  • 09 Aug, 2022
  • +33 other locations
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis (VANTAGE)

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.

cholangitis
bile acid
Advanced Research Institute, Inc
 (4.5 away) Contact site
  • 0 views
  • 11 Aug, 2022
  • +24 other locations
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)

Researchers are looking for a better way to treat women who have hot flashes after women have been through the menopause. Hot flashes are caused by the hormonal changes that happen when a woman's body has been through the menopause. Menopause is when women stop having a menstrual cycle, also …

Suncoast Clinical Research Center, Inc.
 (4.7 away) Contact site
  • 0 views
  • 21 Jul, 2022
  • +61 other locations
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Accepts healthy volunteers
regular menstrual cycles
hormonal contraception
Mylan Investigator Site
 (7.9 away) Contact site
  • 20 views
  • 29 Jul, 2022
  • +44 other locations
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis stage 2 or 3

Advanced Research Institute
 (4.5 away) Contact site
  • 6 views
  • 04 Jul, 2022
  • +120 other locations
ALPN-101 in Systemic Lupus Erythematosus (Synergy)

This is Phase 2, multinational, randomized, blinded study to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacokinetics and pharmacodynamics of ALPN-101 in adults with moderate to severe active systemic lupus erythematosus (SLE)

lupus
human papilloma virus vaccine
Investigational Site (151)
 (7.9 away) Contact site
  • 0 views
  • 25 Jul, 2022
  • +55 other locations
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause (OASIS-3)

Researchers are looking for a better way to treat women who have hot flashes after they have been through the menopause. Hot flashes are caused by the hormonal changes that happen when a woman's body has been through the menopause. Menopause is when women stop having a menstrual cycle, also …

Suncoast Clinical Research Center, Inc.
 (4.7 away) Contact site
  • 98 views
  • 24 Jul, 2022
  • +68 other locations